Next Article in Journal
Sustainable Innovations in Food Microbiology: Fermentation, Biocontrol, and Functional Foods
Previous Article in Journal
Effects of Dietary Fiber Supplementation on Chronic Constipation in the Elderly: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Engineering High-Amylose and High-Dietary-Fibre Barley Grains Through Multiplex Genome Editing of Four Starch-Synthetic Genes

1
Institute of Quality Standard and Testing Technology Research, Sichuan Academy of Agricultural Sciences, Chengdu 610066, China
2
State Key Laboratory of Crop Gene Exploration and Utilisation in Southwest China, Triticeae Research Institute, Sichuan Agricultural University, Chengdu Campus, Chengdu 611130, China
3
Agriculture and Food, Commonwealth Scientific and Industrial Research Organisation, Black Mountain, Canberra, ACT 2601, Australia
*
Authors to whom correspondence should be addressed.
Foods 2025, 14(13), 2319; https://doi.org/10.3390/foods14132319
Submission received: 4 May 2025 / Revised: 18 June 2025 / Accepted: 25 June 2025 / Published: 30 June 2025
(This article belongs to the Section Grain)

Abstract

Barley, rich in beneficial ingredients, has been recognised as a healthy food and is widely used in the production of healthy foods for humans. The current study identified a new barley mutant with the SSIIa, SSIIIa, SBEIIa, and SBEIIb genes inactivated in the genome-edited offspring of targeted mutagenesis of starch synthetic genes using multiplex genome editing. The grain compositions and starch properties of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant were analysed and compared with the corresponding parameters of ssIIa, ssIIIa, sbeIIa/sbeIIb, ssIIa/sbeIIa/sbeIIb, and non-genome-edited lines (NE), respectively. ssIIa/ssIIIa/sbeIIa/sbeIIb exhibited the highest contents of β-glucan and amylose content among all mutants and NE, but not the most prominent in resistant starch, fructan, and fibre contents. The loss of SSIIa, SSIIIa, SBEIIa, and SBEIIb genes also resulted in significant changes in starch properties. This study enriched the genotypes of healthy barley and provided a theoretical basis for improving barley quality.

1. Introduction

Barley (Hordeum vulgare L.) is a type of conventional, cultivated cereal, accounting for approximately 12% of the world’s total cereal production [1,2]. Historically, barley grains were primarily used as feed grains and in the brewing and distilling industry, such as beer brewing and other food production [3]. More recently, attention has turned to the nutritional and chemical properties of the biologically active constituents in barley grain. Barley is considered the most suitable grain for the human diet due to the high dietary fibre content and the high proportion of soluble viscous fibre components. The hypoglycaemic and hypocholesterolemic functions of β-glucan also suggest that barley-based foods are good for human health [4].
The primary reserve storage polysaccharide of barley grain is starch, which accounts for about 60% of the dry weight of barley grain. Typically, the total starch in barley grain contains about 25% amylose, with the remaining portion being amylopectin [5,6]. However, unique barley materials were created in previous studies; high-amylose barley contained more than 80% amylose content, and waxy barley had about 100% amylopectin content [2,7]. The biosynthesis of starch in barley grains was like that in other cereals, which is coregulated by enzymes named ADP-glucose Pyrophosphorylase (AGPase), granule-bound starch synthase (GBSS), soluble starch synthase (SSS), starch branching enzyme (SBE), and starch debranching enzyme (DBE). Each was divided into several types based on their roles in starch biosynthesis [8]. GBSS was essential for the biosynthesis of amylose, and SSS and SBE enzymes were coordinated to regulate amylopectin synthesis. Previous studies have indicated that the amylose (Am) and amylopectin (Ap) contents, as well as the Am/Ap ratio, can influence the quality of starch-based products. Recently, considerable attention has been focused on a specific type of starch known as resistant starch (RS), which remains undigestible both in vitro and in vivo. Products based on RS have been identified as a healthy food source for individuals with diabetes. Previous studies have indicated that cereals with higher amylose content typically have a higher resistant starch (RS) content than regular barley [9]. Therefore, barley with high amylose (RS) content makes a positive contribution to the production of healthy food.
Genetic improvement is the most effective means of breeding plants with target phenotypes in crop breeding for various crops. Mutants with superior agronomic traits were obtained by large-scale screening, and the beneficial phenotypes were transferred to other cultivated varieties for crop improvement by crossing. Chemical mutagenesis is a common and effective method for inducing mutants with superior agronomic traits. It has been successfully used for breeding barley with high amylose content, wheat with high resistance to stem rust, and rice with high nutritional value [10,11,12]. However, the mutations induced by chemical mutagenesis were uncertain, and identifying mutants with targeted genotypes and phenotypes is laborious and time-consuming. A succession of backcrosses was required to reduce the other mutation sites in the mutant backgrounds induced by chemical mutagenesis before they could be used for crop improvement. These deficiencies limited the large-scale use of chemical mutagenesis in crop genetic improvement. Genetic engineering technology is an effective means to realise the improvement of donor cereals. The targets and timelines of genetic engineering means are more predictable than other standard genetic improvement methods. To date, it has been successfully utilised to enhance the yield, quality, and resistance of crops [13]. Although the public worries about the bio-safety of GM products, the convenience and effectiveness of transgenic technology vigorously promote its application in crop improvement.
The CRISPR/Cas9 system is a valuable genetic tool for inducing targeted mutagenesis. A genome-editing construct containing the Cas9 gene and guide RNA expression cassettes was first transformed into the donor plant. The targeted DNA double-strand breaks (DSBs) were induced in the transformed plant cells, and indels were introduced during the non-homologous end joining (NHEJ) or homologous recombination (HR) repair processes. Homozygous mutants of target genes can be easily identified in the offspring of mutant plants using molecular biological methods, and transgene-free mutants can be obtained through segregation in self-crossing or backcrossing populations of genome-edited lines [14]. CRISPR/Cas9 gene-editing technology made it easy to realise targeted mutagenesis, and the identification process was more effective and efficient due to the lack of random mutagenesis, saving time for laborious screening. So far, CRISPR/Cas9 is recognised as the most effective technology for studying the function of endogenous genetic factors in cereals [15,16,17]. Additionally, the CRISPR/Cas9 genome-editing technology is a powerful tool for producing mutations in multiple genes within a single transgenic event. It avoids the complicated process of multiple genetic transformation work or the time-consuming process of crosses among multiple mutants to create polygenic mutants. Due to its simple operations, multiplex gene editing technology has become the most frequently used method for creating targeted mutants. To date, it has been successfully applied to the improvement of rice, wheat, barley, and other crops [13]. Our earlier published paper demonstrated that 14 out of 155 T0 barley plants harboured heterozygous or homozygous mutations for all four genes, including three plants with homozygous mutations for one gene and two plants with homozygous mutations for two genes [18]. All four genes were fully inactivated in the quadruple mutant, as they all lost their protein expression, as shown below.
In a previous study, a barley mutant with the ssIIa gene inactivated was created using chemical mutagenesis and targeted genome editing. The starch properties and the mechanism of the increased resistant starch (RS) content in SSIIa null mutants were analysed. In addition, the ssIIa null mutant, BARLEYmax, with high resistant starch content, has been widely used worldwide. Experiments on pigs and rats have shown that feeding BARLEYmax benefits the animals’ health [19,20,21], suggesting that BARLEYmax food containing high RS content can improve human health. Additionally, the multiplex genome-editing system was utilised for the targeted editing of genes related to amylopectin synthesis in barley. Various mutants, genotyped as ssIIa, ssIIIa, ssIVa, sbeIIa, sbeIIb, ssIIa/ssIIIa, ssIIa/ssIVa, sbeIIa/sbeIIb, ssIIa/ssIIIa/ssIVa, and ssIIa/sbeIIa/sbeIIb, were obtained through a single transgene event via Agrobacterium-mediated genetic transformation of barley immature embryos. Grain ingredients and starch properties of different mutants were analysed to study the effect of SSIIa, SSIIIa, SSIVa, SBEIIa, and SBEIIb in barley starch biosynthesis [18]. The studies above systematically analysed the functions of amylopectin synthesis-related genes in producing RS in barley grains. However, creating barley mutants with different genotypes remains the most effective way to further investigate the function of related genes and their synergistic relationship. In the current study, a four-gene mutant, genotyped as ssIIa/ssIIIa/sbeIIa/sbeIIb, was identified in the progeny of genome-edited mutants created in a previous study. The grain morphology, various composition parameters, and starch properties of ssIIa/ssIIIa/sbeIIa/sbeIIb were analysed and compared to the corresponding parameters in ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb, respectively. These results further demonstrated the effect of ssIIa, ssIIIa, sbeIIa, and sbeIIb in the biosynthesis of barley starch.

2. Materials and Methods

2.1. Plant Materials

The genome-edited barley T0 lines, induced by Agrobacterium tumefaciens-mediated transformation of recombinant Agrobacterium with a genome-editing construct, were used to identify mutants with target genotypes. The procedures were described in detail previously for constructing the multiplex genome-editing construct, barley transformation, screening of transgenic positive T0 plants, and genotyping of T0 plants [18]. All T0 plants were grown in a glasshouse at the plant growth facility of CSIRO Agriculture and Food (Canberra, ACT, Australia) at 25 °C under natural light conditions. The transgenic donor Golden Promise and non-genome-edited lines grown side by side with mutant lines were used as controls.

2.2. Identification of ssIIa/ssIIIa/sbeIIa/sbeIIb Mutants

The genome-edited transgenic T0 lines containing mutations in the SSIIa, SSIIIa, SBEIIa, and SBEIIb genes were selected to identify ssIIa/ssIIIa/sbeIIa/sbIIb mutants. Based on the number of mutant target genes contained in the genome-edited T0 plant, different numbers of dried T1 grains were randomly selected from the progenies of each selected T0 mutant. All of them were germinated and transplanted into the soil, and the genomic DNA of each T1 plant was extracted. The genotype of each T1 plant was analysed using KASP markers, which were designed based on the genotype of the corresponding T0 plant at each sgRNA site. Based on the results of KASP detection, the T1 generation plants with target genotypes were selected for subsequent studies. The genotypes were then confirmed by Sanger sequencing with the primer pairs to identify the corresponding sgRNA site [18]. The T1 plants with genotype ssIIa/ssIIIa/sbeIIa/sbeIIb were transplanted into large pots, and mature grains were harvested for the subsequent study.

2.3. Grain Weight

The mature grains of T2 plants with genotype ssIIa/ssIIIa/sbeIIa/sbeIIb were harvested and dried in a 37 °C oven. The 50-grain weight of ssIIa/ssIIIa/sbeIIa/sbeIIb was measured and converted to a 1000-grain weight. The average grain weight was calculated as the mean of triplicate measurements of 1000 grains for each T2 mutant plant.

2.4. Microscopic Examination of Barley Grains

Fifty grains of each ssIIa/ssIIIa/sbeIIa/sbeIIb mutant plant were randomly selected to measure the average grain length, width, and area. Grains were randomly spread on the sample plate, leaving sufficient space between seeds. The original images of grain morphological parameters were recorded using the Epson Perfection V330 Photo scanner (Epson, Suwa, Nagano, Japan). The data on grain length, width, and area of each grain were analysed by the supporting software CSIRO GrainScan version 3. Additionally, a camera and a Leica microscope digital camera (M80, Leica, Wetzlar, Germany) were used to record the grain shape in multiple grains and individual grains, respectively. The mature grains of non-genome-edited lines (NE) were used as the negative control.

2.5. Starch Extraction

The mature grains of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant and NE lines were used to extract the starch granules. The procedure has been described in detail [18]. Dried mature grains were milled by ESPE CapMixTM (model 3M, Seefeld, Germany), and treated with Hydrochloric acid (0.02 M), NaOH solution (0.2M), 0.1M Tris-HCl buffer (pH 7.6, containing 0.5% sodium metabisulphite), protease K (LS004224, Worthington Biochemical, Lakewood, NJ, USA), and Percol (17-0891-01, GE Healthcare, Mascot, NSW, Australia) in the successive procedure. The starch suspension was used to analyse the starch granule particle size directly, and the remaining part was dried in a freeze-dryer (BenchTop Pro with Omnitronics, SP SCIENTIFIC, Warminster, PA, USA) and stored at 4 °C for analysis of the starch composition and properties.

2.6. SDS-PAGE and Immunoblotting Analysis

The purified and dried starch granules were used to extract granule-bound proteins (GBPs) SSIIa, SBEIIa, and SBEIIb. A 4 mg sample of starch was accurately weighed and homogenised with 60 µL of extraction buffer containing 5% SDS, 10% glycerol, 5% β-mercaptoethanol, 50 mM Tris buffer (pH 6.8), and bromophenol blue in a 1.5 mL centrifuge tube. The starch-containing tubes were vortexed, boiled for 10 min, and then centrifuged at 13,000 rpm (model 5424, Eppendorf AG, Hamburg, Germany) for 20 min at 4 °C. For SDS-PAGE analysis, a 25 µL supernatant was pipetted onto a mini PAGE gel (NuPAGETM 4–12% Bis-Tris Gel, NP0322BOX, Thermo Fisher, Santa Clara, CA, USA). For analysing the protein expression of SSIIIa, one or two immature endosperms were homogenated with 200 µL extraction buffer containing 50 mM KPi pH 7.5, 5 mM EDTA, 20% glycerol, 1 mM PIC, and 10 mM DTT in a 1.5 mL centrifuge tube using a pestle, and then were centrifuged at 14,000 rpm for 15 min at 4 °C immediately. The supernatant was transferred to a new Eppendorf tube, and 5 µL of it were used for quantifying the protein content using a Coomassie Plus Protein Assay Reagent kit (23238, Thermo Fisher, Santa Clara, CA, USA). The protein samples loaded onto the same gel were diluted to the same concentration with the extraction buffer. An equal volume of 2 × SDS loading buffer was added to each tube and mixed well using a pipette containing 100 mM Tris-HCl, 20% glycerol, 4% SDS, and 0.2% bromophenol blue. The protein-containing tubes were vortexed, boiled for 5 min, and transferred to ice immediately. In total, 25 µL of the mixture were pipetted onto a mini PAGE gel for SDS-PAGE analysis.
The electrophoresis and immunoblotting procedures were the same for analysing both GBPs and soluble starch synthases. Electrophoresis was performed in MOPS–Tris–SDS buffer (50 mM MOPS, 50 mM Tris, 0.1% SDS, and 1 mM EDTA) using a Mini gel tank (Life Technologies, Thermo Fisher, Santa Clara, CA, USA) with a constant voltage of 100 V for 140 min.
After electrophoresis, the gels were removed gently, rinsed in water, soaked in ethanol (20%) for ten minutes, and rinsed in Milli Q water. A preheated iBlot 2 Dry Blotting System (IB1001, Invitrogen, Life Technologies, Thermo Fisher, Santa Clara, CA, USA) was used to transfer proteins from the gel onto a PVDF membrane using the P0 program. The PVDF membranes were soaked in TTBS buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 2.5 mM KCl, and 0.1% Tween 20) containing 3% skim milk immediately, with slow shaking at 30 rpm at room temperature for 1 h. The PVDF membranes were removed with tweezers and soaked in a TTBS buffer containing 0.2% skim milk and a suitable concentration of the tested primary antibody against the corresponding target protein. The membranes were incubated overnight at 4 °C with slow shaking at 30 rpm. The membrane was washed with TTBS for 30 min, during which the TTBS was changed twice. The membrane was incubated in TTBS containing 0.2% skim milk and a suitable concentration of goat anti-rabbit IgG (H + L) with HRP conjugate (170-6515, BIO-RAD, USA) at room temperature for 30 min with slow shaking at 30 times per minute. The washing step was repeated, and the membranes were washed three times with TTBS for 10 min each time. The membranes were lifted with tweezers, wrapped with Super Signal West Pico Plus solution (34580, Thermo Fisher, USA), and imaged using myECL imager (62236x, Thermo Fisher, Santa Clara, CA, USA) [6].

2.7. Microscopic Imaging and Particle Size Analysis of Barley Starch Granules

A scanning electron microscope (SEM) (EVO LS15, ZEISS, Jena, Germany) was used to observe and record the morphology of the barley starch granules. The purified and dried barley starch granules of different mutants and controls were fixed on an aluminium stub and coated with gold particles. Images were taken using the SEM at a voltage of 20 kV with a 1000× magnification.
The purified starch slurries were used to analyse the starch granule size distribution using Mastersizer 3000 (Malvern Instruments, Malvern, UK). The procedures were performed according to the manufacturer’s instructions. The starch granules were divided into A-type (>10 μm) and B-type (1–10 μm) according to the cut-off diameters, and the volume percentages of A and B types were calculated, respectively. The A-type starch granules were also subdivided into three groups: A1 granule (10–20 μm), A2 granule (20–60 μm), and A3 granule (60–120 μm). The differences were calculated in the B-type, A1, A2, and A3 granule compositions between ssIIa/ssIIIa/sbeIIa/sbeIIb and other mutants [6].

2.8. Measurement of Grain Ingredients

A series of Megazyme’s commercial kits (No. K-TSTA; No. K-RSTAR; No. K-BGLU; No. K-FRUCHK; No. K-TDFR, Megazyme, Wicklow, Ireland) were used to analyse the contents of total starch, resistant starch, β-glucan, fructan, and total dietary fibre in ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains, respectively. The dried mature barley grains were milled to pass a 0.5 mm screen using ESPE CapMixTM (model 3M, Seefeld, Germany). The barley wholemeal was dried in a 37 °C oven until there was no further weight loss, and the dried wholemeal was weighed according to the requirements of different Megazyme kits for grain content analyses. The procedures followed the manufacturer’s instructions, and each parameter of a different sample was performed in triplicate.
The apparent amylose content of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant barley was assayed using the iodine-binding method [22], described in detail in our previous study [23].

2.9. Analyses of Starch Structure and Properties

The amylopectin chain length distribution of debranched ssIIa/ssIIIa/sbeIIa/sbeIIb mutant starch was analysed using a fluorescence-activated capillary electrophoresis (7100 Capillary Electrophoresis, Agilent Technologies, Santa Clara, CA, USA). The procedures were performed with minor modifications to the previous method [24]. About ten milligrams of purified starch for each test sample were weighed and dissolved in 375 μL distilled water and 25 μL NaOH (2M) in a 1.5 mL centrifuge tube. The starch samples were boiled for 5 min and then cooled at room temperature. Then, solutions were added to the sample tubes in turn, including 16 μL of glacial acetic acid, 50 μL of sodium acetate (1M), 500 μL distilled water, and 5 μL of the iso-amylase enzyme (Megazyme, Wicklow, Ireland), and the tubes were thoroughly vortexed after each solution was added. The tubes were incubated in a 37 °C water bath for 2 h and then boiled for 10 min. A 100 μL mixture was transferred into a new 1.5 mL Eppendorf tube and dried in a speed vacuum (SAVANT DNA 120 SpeedVac Concentrator, Thermo Scientific, Scoresby, VIC, Australia). A 7 μL APTS (8-amino-1,3,6,-pyrenetrisulfonic acid) solution (containing 5 mg APTS labelling dye in 48 μL 15% acetic acid) and 7 μL sodium cyanoborohydride solution (6.3 mg dissolved in 100 µL distilled water) were added to dissolve the dried sample, and the sample tubes were incubated for ten to 14 h in a 50 °C bio-shaker with 350 rpm shaking speed. After incubation, 60 μL of distilled water were added to each tube to dilute the sample. The tubes were then boiled for 1.5 min and immediately spun for 30 s in a microcentrifuge. The mixture was filtered through a Wizard miniColumn (Promega part A7211) and used for fluorescence-activated capillary electrophoresis. The results were analysed by the supporting software of the P/ACE 5510 capillary electrophoresis system (Beckman, Brea, CA, USA) with agron-LIF detection.
Based on the structural differences between amylose and amylopectin, the amylose content of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant was measured using high-performance liquid chromatography (HPLC). The procedures were performed according to the method described by Batey and Curtin with a minor change [25]. For each sample, approximately 5 milligrams of purified starch were weighed and dissolved in 500 μL UDMSO (90% DMSO containing 0.6 M Urea) in a 1.5 mL tube. The mixture was then incubated overnight at 80 °C in a bio-shaker at 400 rpm. After 500 μL of 80 °C preheated distilled water were added to dilute the sample, 100 μL of the mixture were loaded for HPLC to analyse the amylose content of the branched starch sample. The remaining mixture was cooled to 40 °C in a 40 °C bio-shaker. In total, 100 μL of acetate buffer (0.5 M, pH 4.0) and 8 μL of normal iso-amylase enzyme (Megazyme, Wicklow, Ireland) were added in turn, and the mixture was incubated at 40 °C with 800 rpm shaking for 3.5 h. The samples were then heated up to 80 °C and incubated for one hour. After 0.2 g of resin were added, the tubes were incubated at 60 °C, shaken at 1000 rpm for 30 min, and centrifuged at 5000 rpm for 5 min. The mixture was filtered through a 0.45 μm filter membrane and used to analyse the amylose content of the debranched starch sample.
The swelling power and solubility of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant barley starch were measured with a 20 mg swelling test method. The moisture content of barley starch was equilibrated by leaving the dried sample with the lid open at room temperature for 10 to 16 h. The labelled 2 mL screw-cap tubes were dried in a 75 °C oven for one hour with the lids open. After closing the lids, the tubes were transferred to a desiccator and cooled down to room temperature. The tube weights were weighed and recorded as W1. About 20 mg of starch were weighed and added to the corresponding tube, and the exact weight of starch was recorded as W2. One millilitre of distilled water was added to dissolve the starch, and the tubes were incubated in a 92.5 °C water bath for 30 min. Twenty iterations of inverted mixings were performed in the first minute, followed by two iterations of inverted mixings at 1.5 min, 2 min, 3 min, 4 min, 5 min, 7.5 min, 10 min, 15 min, and 25 min. Tubes were transferred into a 20 °C water bath and cooled for 3 min, followed by two rounds of inverted mixing at both 0 and 1.5 min time points. The tubes were immediately centrifuged for 10 min at 14,000 rpm, and the supernatant was removed using a pipette. The tubes with open lids were placed in a 75 °C oven to dry the samples for one hour. After closing the lids, the tubes were transferred to a desiccator and cooled to room temperature. The tube weights were then recorded as W3. After opening the lids, the sample tubes were placed in a 75 °C oven and dried to a constant weight in a 37 °C oven. The tubes were transferred into a desiccator with lids closed for cooling down for more than half an hour, then weighed once more and recorded as W4. The swelling power and solubility of barley starch were calculated according to the published formulas, respectively. The formulas were: swelling power = (W3 −W1) / (W2 − 8% × W2) and solubility = (W1 + W2 − W4) / (W2 − 8% × W2/100) × 100.
The Differential Scanning Calorimeter (DSC 8000, PerkinElmer, Buckinghamshire, UK) was used to analyse the calorimetry profiles of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant starch. Approximately 60 mg of starch were weighed after the moisture content equilibration, and the exact weight was recorded as W1. The starch was then mixed with X μL of distilled water (the volume of water was calculated using the formula X = 2 × (W1 − W1 × 8%)). Three repeats of the same premixed sample (approximately 50 mg) were sealed in DSC pans, and the weights of the premixed samples were accurately recorded. The DSC pans containing the premixed samples were equilibrated at room temperature for seven days. The pans were used for DSC measurements directly, and the program was performed following the parameters with a 10 °C increase per minute and varying in radians from 20 °C to 140 °C. An empty DSC pan was treated with the same parameters as a reference. The DSC pans were stored at room temperature for one month and used to measure the amylose-lipid dissociation enthalpies with the same parameters. At last, the DSC thermogram was analysed using the instrument software.

2.10. Statistical Analyses

Triplicate measurements were taken for grain size, grain weight, the particle size of starch granules, calorimetry profiles, starch swelling power and solubility, and the contents of total starch, apparent amylose, resistant starch, β-Glucan, fructan, and the total dietary fibre. The data were analysed and expressed as the mean ± standard deviation. The data for NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb were published in our previous study [18]. The differences between the tested samples with different genotypes were analysed using IBM SPSS Statistics 21 and Minitab 19.

3. Results

3.1. Genotypes of ssIIa/ssIIIa/sbeIIa/sbeIIb Mutants

In our previous study, 155 T0 barley plants were obtained by transforming barley immature embryos with a recombinant Agrobacterium carrying a genome-editing construct. Of these, 152 were alive, and 113 were identified as genome-edited mutants containing one to six targeted gene mutations [18]. Based on the sequencing results of these T0 mutant plants, both T0-60 and T0-89 were identified as genome-edited mutants that contained heterozygous mutations for the SSIIa, SSIIIa, SBEIIa, and SBEIIb genes (Figure 1A). Approximately 400 of the T1 offspring of T0-60 and T0-89 were germinated and planted for the screening of ssIIa/ssIIIa/sbeIIa/sbeIIb homozygous mutants. KASP genotyping was used to analyse the genotype of each T1 plant preliminarily, and the genotypes of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutants identified by KASP analysis were subsequently verified using Sanger sequencing. Finally, two T1 progenies of the T0-60 line, T1 60-26 and T160-161, and one T1 offspring of the T0-89 line, T1 89-202, were identified as ssIIa/ssIIIa/sbeIIa/sbeIIb heterozygous mutants.
The genotypes of T2 generation plants were analysed to illustrate the inheritance of mutations in different generations. Five T2 generation plants (T2 60-26-1 and T2 60-26-73, T2 60-161-11, T2 89-202-7, and T2 89-202-45) were randomly selected from the progeny of T1 60-26, T1 60-161, and T1 89-202, respectively. The genotypes were analysed by Sanger sequencing and are shown in Figure 1B. T2 60-26-1 and T2 60-26-73 mutants had a T insertion in the SSIIa gene, an A insertion in the SSIIIa gene, an A insertion in the SBEIIa gene, and an A deletion in the SBEIIb gene. The genotype of T2 60-161-11 was identical to that of T2 60-26-1 and T2 60-26-73, except for a 47 bp deletion in the SSIIIa gene. Both T2 89-202-7 and T2 89-202-45 contained a T insertion in the SSIIa gene, a C deletion in the SSIIIa gene, a T deletion in SBEIIa, and an A insertion in the SBEIIb gene. It was found that all the T2 plants had the same genotype as the corresponding T1 generation.

3.2. The Protein Expression Levels of the Mutation Genes in the ssIIa/ssIIIa/sbeIIa/sbeIIb Mutants

The protein expression levels of SSIIa, SSIIIa, SBEIIa, and SBEIIb genes in the ssIIa/ssIIIa/sbeIIa/sbeIIb mutants were analysed by immunoblotting using antibodies specific to each gene. The purified starch granules of mature barley grains were used to extract GBPs to analyse the expression level of SSIIa, SBEIIa, and SBEIIb. Immature endosperms at 15 days post-anthesis were used to extract proteins for analysing the expression levels of the soluble starch synthetase gene SSIIIa. Equal amounts of protein were loaded into different holes on one gel, and Western blotting was used to display the results and quantify the expression level of each mutation gene. The immunoblot assays using specific antisera revealed no detectable protein expression encoded by the SSIIa, SSIIIa, SBEIIa, and SBEIIb genes in ssIIa/ssIIIa/sbeIIa/sbeIIb mutants (Figure 1C).

3.3. The Morphology and Sizes of the ssIIa/ssIIIa/sbeIIa/sbeIIb Mutant Grains

The camera images and stereo microstructure of ssIIa/ssIIIa/sbeIIa/sbeIIb T3 mature grains were captured using a digital camera and a digital microscope camera system, respectively. The images of non-genome-edited barley grains resembled those of the mature grains of the transgenic donor, Golden Promise, as reported in previous studies. All the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains showed a shrunken endosperm, with an unfilled central region of the dorsal side of barley grains, and the invagination of the abdominal side was more severe than that of the non-genome-edited mature grains (Supplementary Figure S1).
The average 1000-grain weight of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grain was 30.80 ± 0.20 g, which was significantly lower than that in the NE, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb, respectively, and there were no significant differences between ssIIa/ssIIIa/sbeIIa/sbeIIb and ssIIa mutants in the 1000-grain weight (Supplementary Figure S2A).
The dimensions of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains were measured using the scanning equipment, and the size parameters were analysed. The average grain length of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains was 8.60 ± 0.17 mm, which was significantly shorter than that in NE, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb. The average grain width of ssIIa/ssIIIa/sbeIIa/sbeIIb (3.18 ± 0.05 mm) was significantly lower than that in NE, ssIIa, and ssIIIa. There were no significant differences in the grain width among ssIIa/ssIIIa/sbeIIa/sbeIIb, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb mutants. For the grain area, there was no significant difference between ssIIa/ssIIIa/sbeIIa/sbeIIb (21.60 ± 0.54 mm2) and ssIIa/sbeIIa/sbeIIb. In addition, the grain area of ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly smaller than that in NE and mutants with other genotypes (Supplementary Figure S2B).

3.4. The Composition of ssIIa/ssIIIa/sbeIIa/sbeIIb Mutant Grain

The contents of total starch, apparent amylose, resistant starch, β-glucan, fructan, and total dietary fibre in ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains were measured and compared with those in NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb. The total starch content of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant was 30.51 ± 0.99%, about half of that in NE, which was significantly lower than that in ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb. However, there was no significant difference between ssIIa/ssIIIa/sbeIIa/sbeIIb and ssIIa mutants in total starch content (Figure 2A). The apparent amylose content in each mutant was much higher than that in NE. The apparent amylose content of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant (95.46 ± 0.52%) was significantly higher than that in ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb, which was four times higher than that in NE (Figure 2B). The resistant starch content of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant was 5.97 ± 0.41%, which was about twenty times that of NE, two times that of the ssIIa mutant, and eight times that of the ssIIIa mutant, respectively, and about one-half and two-fifths that of sbeIIa/sbeIIb and ssIIa/sbeIIa/sbeIIb, respectively. In general, the content of resistant starch in ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly higher than that in NE, ssIIa, and ssIIIa, and significantly lower than that in sbeIIa/sbeIIb and ssIIa/sbeIIa/sbeIIb. In addition, the data showed that the resistant starch content in mutants with SBEIIa and SBEIIb genes knocked out was significantly higher than that in other mutants (Figure 2C). The contents of β-glucan, fructan, and fibre in ssIIa/ssIIIa/sbeIIa/sbeIIb mutants were 3.32 ± 0.11%, 2.24 ± 0.13%, and 34.02 ± 0.99%, respectively, which were significantly higher than the contents of corresponding components in NE. The β-glucan content of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant was considerably higher than that in ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb (Figure 2D). The fructan content in ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly higher than that in ssIIIa and ssIIa/sbeIIa/sbeIIb, significantly lower than that in ssIIa. There was no significant difference between sbeIIa/sbeIIb and ssIIa/ssIIIa/sbeIIa/sbeIIb in the fructan content (Figure 2E). The ssIIa/ssIIIa/sbeIIa/sbeIIb mutant had a similar level of fibre content as other mutants, except that in ssIIIa, which was significantly higher than that in NE and ssIIIa mutants (Figure 2F).

3.5. The Amylose Content of ssIIa/ssIIIa/sbeIIa/sbeIIb Mutant Grains

The amylose content (Am) of ssIIa/ssIIIa/sbeIIa/sbeIIb was measured based on the microstructure difference between amylose and amylopectin. The amylose content of ssIIa/ssIIIa/sbeIIa/sbeIIb in native and debranched starch was analysed using HPLC, respectively. In the native starch, the Am in ssIIa/ssIIIa/sbeIIa/sbeIIb (71.55 ± 1.13%) was approximately twice that in NE and ssIIIa, and significantly higher than that in ssIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb. The Am of debranched ssIIa/ssIIIa/sbeIIa/sbeIIb starch (73.61 ± 2.69%) was significantly higher than that in ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb, and six times higher than that in debranched NE starch. For ssIIa/ssIIIa/sbeIIa/sbeIIb mutant, the Am of debranched starch was higher than that in native starch; a similar situation was found in the Am of ssIIa and ssIIIa mutants. However, the Am of debranched starch was lower than that in native starch in sbeIIa/sbeIIb, ssIIa/sbeIIa/sbeIIb, and NE. The difference in Am in native and debranched starch of ssIIa/ssIIIa/sbeIIa/sbeIIb was less than that of NE and all the other mutants (Figure 3A).

3.6. Starch Swelling Power and Solubility

The swelling power and solubility of the purified ssIIa/ssIIIa/sbeIIa/sbeIIb starch were measured. The result showed that the swelling power of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant was 1.97 ± 0.11%, significantly lower than that in NE, ssIIa, and ssIIIa null mutants. There were no significant differences among sbeIIa/sbeIIb, ssIIa/sbeIIa/sbeIIb, and ssIIa/ssIIIa/sbeIIa/sbeIIb in starch swelling power with the inactivated SBEIIa and SBEIIb genes. The solubility of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant was 32.83 ± 1.85%, about three times that of NE, which was higher than that of NE, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb significantly. However, there were no significant differences among ssIIa, ssIIIa, and ssIIa/ssIIIa/sbeIIa/sbeIIb mutants in the starch solubility (Figure 3B).

3.7. Chain Length Distribution of Debranched Starch

The chain length distribution of ssIIa/ssIIIa/sbeIIa/sbeIIb debranched starch was analysed by fluorescence-activated capillary electrophoresis (FACE). The differences in chain length distributions between ssIIa/ssIIIa/sbeIIa/sbeIIb null mutant and other mutants were calculated. The data of NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb were subtracted from the ssIIa/ssIIIa/sbeIIa/sbeIIb, respectively, as shown in Figure 4. Based on the published division criteria, the amylopectin molecule chains were divided into four groups named short, medium, long, and very long chains, with chain lengths of DP6-12, DP13-24, DP25-36, and DP > 36, respectively. The differences between the ssIIa/ssIIIa/sbeIIa/sbeIIb null mutant and other mutants in each group were digitised and presented in Table 1. The results showed that ssIIa/ssIIIa/sbeIIa/sbeIIb had a higher proportion of short chains than that in NE and ssIIIa, and lower proportions of the medium, long, and very long chains than that in NE and ssIIIa null mutants. The ssIIa/ssIIIa/sbeIIa/sbeIIb had higher proportions of medium chains and lower proportions of short, long, and very long chains than those in the ssIIa null mutant. The proportions of short and medium chains in ssIIa/ssIIIa/sbeIIa/sbeIIb were higher and lower than those in both sbeIIa/sbeIIb and ssIIa/sbeIIa/sbeIIb mutants, respectively. There were no noticeable differences among sbeIIa/sbeIIb, ssIIa/sbeIIa/sbeIIb, and ssIIa/ssIIIa/sbeIIa/sbeIIb for the proportions of long and very long chains.

3.8. The Granule Morphology and Particle Size Distribution of Barley Starch

The purified starches extracted from NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, ssIIa/sbeIIa/sbeIIb, and ssIIa/ssIIIa/sbeIIa/sbeIIb were used to analyse the morphology of starch granules (Figure 5A-F). The results showed that the morphologies of NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb starch granules were consistent with the published starch microstructure. The morphologies of NE starch granules were typical of barley starches, containing a certain amount of A-type and B-type starch granules with spherical granular morphology. There were apparent differences between mutants and NE in the shapes and compositions of starch granules. The A-type starch granules in ssIIa showed an apparent hollow surface compared to those of normal starch in NE. The ssIIIa had smaller A-type starch granules and more B-type granules than those in NE. Many distorted A-type starch granules with stick-like, smooth surfaces were observed in sbeIIa/sbeIIb, and some of them exhibited concave surfaces. ssIIa/sbeIIa/sbeIIb had new kinds of spherical A-type starch granules consisting of several small smooth surface granules with or without clear boundaries, and the sizes of those altered granules were like the typical A-type starch granules in NE. All the changes in the size and composition of starch granules in ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb were consistent with the starch microstructure published in our previous study (Figure 5B–F). Compared with NE and other mutants, ssIIa/ssIIIa/sbeIIa/sbeIIb had altered the microstructure of starch granules. ssIIa/ssIIIa/sbeIIa/sbeIIb did not have any B-type starch granules, and all A-type starch granules had abnormal morphologies. A small number of granules were altered with a microstructure similar to those observed in sbeIIa/sbeIIb, and the remaining granules looked like those in ssIIa/sbeIIa/sbeIIb, except that those granules consisted of smaller granules with more explicit boundaries (Figure 5A; Supplementary Figure S3).
The particle size distributions of starch granules of ssIIa/ssIIIa/sbeIIa/sbeIIb were analysed using Mastersizer 3000. The differences in the particle size distributions of starch granules between ssIIa/ssIIIa/sbeIIa/sbeIIb and other mutants were calculated. The percentage of volume of granules with different particle sizes in NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb was subtracted from the data of ssIIa/ssIIIa/sbeIIa/sbeIIb, respectively, as shown in Figure 5G. The starch granules in NE and barley mutants were divided into A- and B-type granules based on their diameter. The volume percentage of A- and B-type starch granules in NE and mutants with different genotypes was calculated, respectively. The results showed that the volume percentage of A- and B-type starch granules in ssIIa/ssIIIa/sbeIIa/sbeIIb was 62.03 ± 0.63% and 37.97 ± 0.63%, respectively (Figure 5H). The volume percentage of A-type starch granules in ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly higher than that in ssIIIa but significantly lower than that in NE. The percentage of the B-type granules in ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly higher than that in NE, whereas it was significantly lower than that in ssIIIa. There were no significant differences among ssIIa/ssIIIa/sbeIIa/sbeIIb, ssIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb in the volume percentage of A- and B-type starch granules.
Figure 5G also showed that inactivating the target genes in different mutants had a dramatic effect on the composition of starch granules (Table 2). There are two peaks above (approximately 10–20 μm and 60–120 μm) and one below (20–60 μm) the zero line of the X-axis, named A1, A2 and A3. The proportion of B-type starch granules in ssIIa/ssIIIa/sbeIIa/sbeIIb was higher than that in NE, but lower than that in other mutants. For the A-type granules, the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant increased A1 size granules compared to NE and all other mutants. However, the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant reduced the proportions of A2 size granules compared with NE. The proportion of A2 and A3 granules in ssIIa/ssIIIa/sbeIIa/sbeIIb was reduced compared with ssIIa and sbeIIa/sbeIIb. Whereas the proportion of A2 and A3 granules in ssIIa/ssIIIa/sbeIIa/sbeIIb was increased compared with ssIIIa and ssIIa/sbeIIa/sbeIIb, respectively.

3.9. Thermal Properties

The thermal properties of the starch from ssIIa/ssIIIa/sbeIIa/sbeIIb mutant were analysed using DSC, and the gelatinisation temperature of ssIIa/ssIIIa/sbeIIa/sbeIIb was calculated and shown in Table S1. For the gelatinisation peak, the onset, peak, and final temperatures of ssIIa/ssIIIa/sbeIIa/sbeIIb were significantly higher than those in NE and ssIIa, but significantly lower than those in ssIIa/sbeIIa/sbeIIb, respectively. The onset temperature of ssIIa/ssIIIa/sbeIIa/sbeIIb was substantially higher than that in ssIIIa, and there were no significant differences between ssIIa/ssIIIa/sbeIIa/sbeIIb and ssIIIa in the peak and end temperatures. Otherwise, the onset and peak temperature of ssIIa/ssIIIa/sbeIIa/sbeIIb were significantly lower than that in sbeIIa/sbeIIb, but there was no significant difference between ssIIa/ssIIIa/sbeIIa/sbeIIb and sbeIIa/sbeIIb in the end temperature. The enthalpy of ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly lower than that in NE and ssIIIa. There were no significant differences between ssIIa/ssIIIa/sbeIIa/sbeIIb and ssIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb. For the gelatinisation temperature of the amylose-lipid dissociation peak, there were no significant differences between ssIIa/ssIIIa/sbeIIa/sbeIIb and sbeIIa/sbeIIb in onset, peak, and end temperatures. The data for ssIIa/ssIIIa/sbeIIa/sbeIIb, ssIIa, and ssIIa/sbeIIa/sbeIIb showed no significant differences in the onset and peak temperatures. For other parameters, the data for ssIIa/ssIIIa/sbeIIa/sbeIIb were all significantly lower than those in other samples with different genotypes. There were no significant differences among ssIIa/ssIIIa/sbeIIa/sbeIb mutant and NE, as well as other mutants for enthalpy.

4. Discussion

4.1. Cas9-Mediated Mutagenesis Produced Barley Mutants

The efficient CRISPR/Cas9 genome editing system for barley has been successfully established, and barley genetic engineering mutants have been produced using CRISPR/Cas9 genome editing technology to target and induce mutations at the promoter region of the HvPAPhy_a gene and the coding region of the HvPM19 gene, respectively [26,27]. The CRISPR/Cas9 system facilitated the study of endogenous genetic factors in barley by enabling targeted mutagenesis of specific genes. The barley mutants with the lost ADPG binding structure of starch synthase IIa (SSIIa) were induced through targeted mutagenesis of SSIIa by CRISPR/Cas9 genome editing [23]. The novel starch phenotype in the ssIIa null mutant barley significantly increased amylose and resistant starch contents, and the starch structure and functions were changed considerably compared to the control, which was consistent with the early reported barley ssIIa null mutant, Himaraya292 (BARLEYmax), induced by the chemical mutagenesis [11]. In addition, the Cas9-mediated multi-gene editing system was successfully utilised for barley gene editing of seven starch biosynthetic genes, with six being edited efficiently in a single transgenic event. A range of homozygous monogenic, double, and triple null mutants were identified in the progenies of mutant lines, and the novel phenotypes of different mutants were analysed [18]. This study identified a homozygous four-gene mutant ssIIa/ssIIIa/sbeIIa/sbeIIb from the same population of genome-edited mutants. Theoretically, a larger-scale screening can identify more mutants with different genotypes, containing one to six mutated genes, from the same population. Both the Cas9-mediated single- and multi-gene editing systems are excellent tools for creating mutants to study the functional elucidation of causal genetic variants and elements in barley. However, the acquisition of homozygous mutants during the multi-gene editing procedure depends on the self-segregation of T0 mutants. The isolation of one genome-edited target site was consistent with Mendelian genetics for the heterozygous mutation of one target gene [28]. Selecting mutations that target multiple genes in a single multi-gene editing event would significantly increase the complexity of identifying homozygous mutant progenies. It is necessary to balance the experimental requirements with the feasibility of identifying homozygous mutant progenies.

4.2. Mutated SSIIa, SSIIIa, SBEIIa, and SBEIIb Genes in Barley Led to the Novel Starch Phenotype and Grain Compositions

The starch properties and grain compositions of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant were analysed and compared with NE and other mutants. The morphology and composition of the starch granules in ssIIa/ssIIIa/sbeIIa/sbeIIb changed more than those in the ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb. No A-type starch granules with normal-sharp in ssIIa/ssIIIa/sbeIIa/sbeIIb were observed as those in NE, and no stick-like starch granules were present in ssIIa/ssIIIa/sbeIIa/sbeIIb as those in sbeIIa/sbeIIb mutant. The starch granules in ssIIa/ssIIIa/sbeIIa/sbeIIb were polyhedron spherical granules with separated small granules or a convex surface, and the polymerised small granules were more obvious than those in ssIIa/sbeIIa/sbeIIb [18]. The percentage volume of the A1, A2, A3, and B-type starch granules in ssIIa/ssIIIa/sbeIIa/sbeIIb was changed compared with that in NE and ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb, showing the changes of starch granule morphology and compositions in ssIIa/ssIIIa/sbeIIa/sbeIIb. ssIIa/ssIIIa/sbeIIa/sbeIIb mutant reduced B granules and increased A1 size granules compared with the other four mutants, reflecting the effect of different target genes in the biosynthesis of starch granules.
A previous study indicated that starch with a higher percentage of DP13-24 average amylopectin branch chain length exhibits higher thermal properties [29]. This study analysed the chain-length distribution and thermal properties of ssIIa/ssIIIa/sbeIIa/sbeIIb using FACE and DSC, respectively. The ssIIa/ssIIIa/sbeIIa/sbeIIb line had a lower portion of DP13-24 chains than that in NE, which was associated with significantly higher gelatinisation temperatures than those in NE. This result contradicted the previous conclusion but was similar to that in ssIIa/sbeIIa/sbeIIb mutants, which contained a lower percentage of DP13-24 and higher gelatinisation temperatures than NE [18].
The mutant grain compositions showed that the ssIIa/ssIIIa/sbeIIa/sbeIIb had significantly higher contents of apparent amylose, resistant starch, β-glucan, fructan, and fibre than those in NE. The contents of apparent amylose and β-glucan in ssIIa/ssIIIa/sbeIIa/sbeIIb were even substantially higher than those in ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb, respectively. However, ssIIa/ssIIIa/sbeIIa/sbeIIb contained significantly lower resistant starch content than those in sbeIIa/sbeIIb and ssIIa/sbeIIa/sbeIIb. It did not consistently support the published conclusion that resistant starch content was positively correlated with the amylose content [9]. Similar results were found in the analysis of the grain composition of ssIIa/ssIIIa/ssIVa, which contained a significantly higher amylose content; however, the resistant starch content was considerably lower than that in ssIIa [18]. One of the potential reasons was that the inactivation of SSIIIa leads to a reduction in the proportion of chains of DP > 37 in starch [6], which may reduce the proportion of the long chains and affect its resistant starch content starch in the quadruple mutant compared to those in sbeIIa/sbeIIb and ssIIa/sbeIIa/sbeIIb. Such a reduction of the long chains was not detected in the chain length distribution of debranched starches between ssIIa/ssIIIa/sbeIIa/sbeIIb and ssIIa/sbeIIa/sbeIIb mutants in our current study. Further studies are needed to understand the mechanisms by which the ssIIIa mutation affects RS content in the quadruple mutant. In our earlier published paper, the amylose content assay methods were compared for barley starches from different gene mutants, including apparent amylose in native starch and debranched starch, and the iodine-binding method [30]. In general, high-amylose starches from all mutant barley lines yielded high amylose values using all three methods. However, different mutants had high amylose phenotypes through various mechanisms. The amo1/ssIIa double mutant produced long-chain amylose molecules, and the sbeIIa/sbeIIb double mutant reduced short chains of amylopectin. Although the iodine-binding method can estimate the high amylose content phenotype, combining apparent amylose in native starch and debranched starch helps explain whether high amylose starch is produced from an increased proportion of long-chain amylose or a reduced proportion of amylopectin. The grain compositions suggested that ssIIa/ssIIIa/sbeIIa/sbeIIb is one of the most promising candidate genotypes for breeding healthy barley.

4.3. Cas9-Mediated Multi-Gene Editing System Helps to Improve the Health Quality of Barley

Like other cereal grains, starch is the principal storage polysaccharide of barley grains, comprising about 25% amylose and 75% amylopectin. Previous studies have shown that the quality of cereal-based foods is significantly influenced by the properties of starch [6,11,31]. The high-amylose starch, with a high amylose/amylopectin ratio, also contained a high resistant starch content, which is beneficial for health [32]. The amylose and resistant starch contents of the ssIIa null barley mutant were significantly higher than those in the control, which proved useful to animal health [1,4,20,32,33]. The barley genetically engineered mutants with single, double, or triple null mutations of the starch biosynthetic genes were induced using the CRISPR/Cas9 multiplex genome-editing system [18]. The sbeIIa/sbeIIb and ssIIa/sbeIIa/sbeIIb mutants contained around four and 35 times more apparent amylose and resistant starch contents than NE, respectively. These mutants would benefit human health and are even superior to the ssIIa null barley mutant. However, the high amylose/resistant starch contents negatively affect grain-eating and cooking qualities [15,34,35]. In the current study, the ssIIa/ssIIIa/sbeIIa/sbeIIb barley mutant was identified from the offspring of a genome-edited mutant induced by a multiplex genome-editing system. The apparent amylose and resistant starch content of ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly higher than that in the control. Moreover, the apparent amylose content of ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly higher than that in ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb. However, the resistant starch content of ssIIa/ssIIIa/sbeIIa/sbeIIb was significantly higher than that in ssIIa and ssIIIa, but considerably lower than that in sbeIIa/sbeIIb and ssIIa/sbeIIa/sbeIIb. Our study enriched the understanding of the various types of amylose and resistant starch contents in barley. Moreover, the contents of β-glucan, fructan, and fibre of ssIIa/ssIIIa/sbeIIa/sbeIIb were significantly increased compared with those in the control, showing potential outstanding health effects. The present study identified a new type of barley with potential health benefits, which provides theoretical guidance and genetic resources for barley breeding. Although no in vivo studies have been done in the quadruple mutant, CSIRO’s early in vivo work on the ssIIa mutant barley grain showed the health benefits of whole grains, fructan, and β-glucan of the mutant barley [20,21,32,36,37,38]. Future in vivo studies may be conducted to validate the health benefits of the quadruple mutant, as demonstrated in the ssIIa mutant barley grain, if the quadruple mutant is selected for breeding and commercialisation.

5. Conclusions

In conclusion, this study generated the barley ssIIa/ssIIIa/sbeIIa/sbeIIb null mutant from the genome-edited offspring of targeted mutagenesis barley lines. The grain composition and starch properties were analysed systematically for ssIIa/ssIIIa/sbeIIa/sbeIIb null barley grains. In comparison with the related single, double, and triple-gene barley mutants, ssIIa/ssIIIa/sbeIIa/sbeIIb showed prominent advantages in the contents of amylose and β-glucan and some advantages in the contents of resistant starch, fructan, and fibre compared to some of the related mutants. This study indicated that ssIIa/ssIIIa/sbeIIa/sbeIIb null mutant barley is a new germplasm for cultivating healthy barley. However, several future works need to be conducted. Firstly, transcriptomic or proteomic research may be conducted to further understand the mechanisms by which gene mutations in the quadruple mutant affect different grain traits, such as high amylose, β-glucan, and fructan contents. Secondly, the in vivo work may also be conducted to validate the health benefits of the quadruple mutant, if required for breeding and commercialisation. Lastly, further research will be conducted on the gene editing of barley grain genes to seek optimised genetic combinations for target grain traits that improve health benefits.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/foods14132319/s1. Figure S1. Stereoscopic and camera photographs of ssIIa/ssIIIa/sbeIIa/sbeIIb T3 mutant grains. Figure S2. Grain weight and dimensions of T3 mutant barley grains. Figure S3. Starch granule morphologies in different ssIIa/ssIIIa/sbeIIa/sbeIIb mutant lines. Table S1. Differences in starch gelatinisation temperatures between ssIIa/ssIIIa/sbeIIa/sbeIIb and other barley mutants.

Author Contributions

Conceptualisation, Q.J. and Z.L.; Methodology, Q.Y., J.-P.R. and Z.L.; Formal Analysis, Q.Y.; Investigation, Q.Y.; Resources, Q.J., J.-P.R. and Z.L.; Writing—Original Draft Preparation, Q.Y.; Writing—Review and Editing, J.-P.R., Q.J. and Z.L.; Supervision, J.-P.R., Q.J. and Z.L.; Funding Acquisition, Q.Y., Q.J., J.-P.R. and Z.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Development of Efficient Gene Editing Systems and Creation of New Germplasm (5 + 1QYGG003), the Ministry of Science and Technology of the People’s Republic of China (MOST) (2023ZD04062), Scientific Research Foundation for the introducing talents, Sichuan Academy of Agricultural Sciences (NKYRCZX2024025), CSIRO Agriculture and Food, Australia (Ph.D. student funds), the Major Program of National Agricultural Science and Technology of China (NK20220607), and the Fund of “1 + 9” Science and Technology Project of the Sichuan Academy of Agricultural Sciences (1 + 9 KJGG 006) and Advanced Technology for Biosafety.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Materials, further inquiries can be directed to the corresponding authors.

Acknowledgments

We thank Wang, H. and Konik-Rose, C. for their technical support in analysing the grain composition and starch properties.

Conflicts of Interest

The authors declare that they have no known conflicts of interest or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Briggs, D.E. Barley; Springer Science & Business Media: New York, NY, USA, 2012. [Google Scholar]
  2. Szczodrak, J.; Pomeranz, Y. Starch and enzyme-resistant starch from high-amylose barley. Cereal Chem. 1991, 68, 589–596. [Google Scholar] [CrossRef]
  3. Zhou, M.X. Barley production and consumption. In Genetics and Improvement of Barley Malt Quality; Springer: Berlin/Heidelberg, Germany, 2009; pp. 1–17. [Google Scholar] [CrossRef]
  4. Pržulj, N.; Grujić, R.; Trkulja, V. Nutritional advantages of barley in human diet. In Central European Congress on Food; Springer: Berlin/Heidelberg, Germany, 2022; pp. 379–388. [Google Scholar]
  5. Fan, X.Y.; Zhu, J.; Dong, W.B.; Sun, Y.D.; Lv, C.; Guo, B.J.; Xu, R.G. Comparative mapping and candidate gene analysis of SSIIa associated with grain amylopectin content in barley (Hordeum vulgare L.). Front. Plant Sci. 2017, 8, 1531. [Google Scholar] [CrossRef] [PubMed]
  6. Li, Z.Y.; Li, D.H.; Du, X.H.; Wang, H.; Larroque, O.; Jenkins, C.L.; Jobling, S.A.; Morell, M.K. The barley amo 1 locus is tightly linked to the starch synthase IIIa gene and negatively regulates expression of granule-bound starch synthetic genes. J. Exp. Bot. 2011, 62, 5217–5231. [Google Scholar] [CrossRef] [PubMed]
  7. Hoseney, R.C. Principles of Cereal Science and Technology; A General Reference on Cereal Foods; American Association of Cereal Chemists: St. Paul, MN, USA, 1986. [Google Scholar]
  8. Myers, A.M.; Morell, M.K.; James, M.G.; Ball, S.G. Recent progress toward understanding biosynthesis of the amylopectin crystal. Plant Physiol. 2000, 122, 989–998. [Google Scholar] [CrossRef]
  9. Hazard, B.; Trafford, K.; Lovegrove, A.; Griffiths, S.; Uauy, C.; Shewry, P. Strategies to improve wheat for human health. Nat. Food 2020, 1, 475–480. [Google Scholar] [CrossRef]
  10. Liu, J.X.; Wu, X.B.; Yao, X.F.; Yu, R.; Larkin, P.J.; Liu, C.M. Mutations in the DNA demethylase OsROS1 result in a thickened aleurone and improved nutritional value in rice grains. Proc. Natl. Acad. Sci. USA 2018, 115, 11327–11332. [Google Scholar] [CrossRef]
  11. Morell, M.K.; Kosar-Hashemi, B.; Cmiel, M.; Samuel, M.S.; Chandler, P.; Rahman, S.; Buleon, A.; Batey, I.L.; Li, Z.Y. Barley sex6 mutants lack starch synthase IIa activity and contain a starch with novel properties. Plant J. 2003, 34, 173–185. [Google Scholar] [CrossRef]
  12. Williams, N.D.; Miller, J.D.; Klindworth, D.L. Induced mutations of a genetic suppressor of resistance to wheat stem rust. Crop Sci. 1992, 32, 612–616. [Google Scholar] [CrossRef]
  13. Chen, K.L.; Wang, Y.P.; Zhang, R.; Zhang, H.W.; Gao, C.X. CRISPR/Cas genome editing and precision plant breeding in agriculture. Annu. Rev. Plant Biol. 2019, 70, 667–697. [Google Scholar] [CrossRef]
  14. Hua, K.; Zhang, J.S.; Botella, J.R.; Ma, C.L.; Kong, F.J.; Liu, B.H.; Zhu, J.K. Perspectives on the application of genome editing technologies in crop breeding. Mol. Plant 2019, 12, 1047–1059. [Google Scholar] [CrossRef]
  15. Huang, L.C.; Li, Q.F.; Zhang, C.Q.; Chu, R.; Gu, Z.W.; Tan, H.Y.; Zhao, D.S.; Fan, X.L.; Liu, Q.Q. Creating novel Wx alleles with fine-tuned amylose levels and improved grain quality in rice by promoter editing using CRISPR/Cas9 system. Plant Biotechnol. J. 2020, 18, 2164. [Google Scholar] [CrossRef] [PubMed]
  16. Xu, Y.; Lin, Q.P.; Li, X.F.; Wang, F.Q.; Chen, Z.H.; Wang, J.; Li, W.Q.; Fan, F.J.; Tao, Y.J.; Jiang, Y.J.; et al. Fine-tuning the amylose content of rice by precise base editing of the Wx gene. Plant Biotechnol. J. 2021, 19, 11. [Google Scholar] [CrossRef] [PubMed]
  17. Zeng, D.C.; Liu, T.L.; Ma, X.L.; Wang, B.; Zheng, Z.Y.; Zhang, Y.L.; Xie, X.R.; Yang, B.W.; Zhao, Z.; Zhu, Q.L.; et al. Quantitative regulation of waxy expression by CRISPR/Cas9-based promoter and 5′UTR-intron editing improves grain quality in rice. Plant Biotechnol. J. 2020, 18, 2385. [Google Scholar] [CrossRef] [PubMed]
  18. Yang, Q.; Ral, J.P.; Wei, Y.M.; Zheng, Y.L.; Li, Z.Y.; Jiang, Q.T. Genome editing of five starch synthesis genes produces highly resistant starch and dietary fibre in barley grains. Plant Biotechnol. J. 2024, 22, 2051–2053. [Google Scholar] [CrossRef]
  19. Aoe, S.; Yamanaka, C.; Fuwa, M.; Tamiya, T.; Nakayama, Y.; Miyoshi, T.; Kitazono, E. Effects of BARLEYmax and high-β-glucan barley line on short-chain fatty acids production and microbiota from the cecum to the distal colon in rats. PLoS ONE 2019, 14, e0218118. [Google Scholar] [CrossRef]
  20. Bird, A.R.; Flory, C.; Davies, D.A.; Usher, S.; Topping, D.L. A novel barley cultivar (Himalaya 292) with a specific gene mutation in starch synthase IIa raises large bowel starch and short-chain fatty acids in rats. J. Nutr. 2004, 134, 831–835. [Google Scholar] [CrossRef]
  21. Bird, A.R.; Jackson, M.; King, R.A.; Davies, D.A.; Usher, S.; Topping, D.L. A novel high-amylose barley cultivar (Hordeum vulgare var. Himalaya 292) lowers plasma cholesterol and alters indices of large-bowel fermentation in pigs. Br. J. Nutr. 2004, 92, 607–615. [Google Scholar] [CrossRef]
  22. Morrison, W.R.; Laignelet, B. An improved colorimetric procedure for determining apparent and total amylose in cereal and other starches. J. Cereal Sci. 1983, 1, 9–20. [Google Scholar] [CrossRef]
  23. Yang, Q.; Ding, J.J.; Feng, X.Q.; Zhong, X.J.; Lan, J.Y.; Tang, H.P.; Harwood, W.; Li, Z.Y.; Guzmán, C.; Xu, Q.; et al. Editing of the starch synthase IIa gene led to transcriptomic and metabolomic changes and high amylose starch in barley. Carbohydr. Polym. 2022, 285, 119238. [Google Scholar] [CrossRef]
  24. O’Shea, M.G.; Morell, M.K. High resolution slab gel electrophoresis of 8-amino-1,3, 6-pyrenetrisulfonic acid (APTS) tagged oligosaccharides using a DNA sequencer. Electrophoresis 1996, 17, 681–686. [Google Scholar] [CrossRef]
  25. Batey, I.L.; Curtin, B.M. Measurement of Amylose/Amylopectin Ratio by High-Performance Liquid Chromatography. Starch 1996, 48, 338–344. [Google Scholar] [CrossRef]
  26. Holme, I.B.; Wendt, T.; Gil-Humanes, J.; Deleuran, L.C.; Starker, C.G.; Voytas, D.F.; Pedersen, B.-H. Evaluation of the mature grain phytase candidate HvPAPhy_a gene in barley (Hordeum vulgare L.) using CRISPR/Cas9 and TALENs. Plant Mol. Biol. 2017, 95, 111–121. [Google Scholar] [CrossRef] [PubMed]
  27. Lawrenson, T.; Shorinola, O.; Stacey, N.; Li, C.D.; Østergaard, L.; Patron, N.; Uauy, C.; Harwood, W. Induction of targeted, heritable mutations in barley and Brassica oleracea using RNA-guided Cas9 nuclease. Genome Biol. 2015, 16, 258. [Google Scholar] [CrossRef] [PubMed]
  28. Yang, Q.; Zhong, X.J.; Li, Q.; Lan, J.Y.; Tang, H.P.; Qi, P.F.; Ma, J.; Wang, J.R.; Chen, G.Y.; Pu, Z.E.; et al. Mutation of the D-hordein gene by RNA-guided Cas9 targeted editing reducing the grain size and changing grain compositions in barley. Food Chem. 2020, 311, 125892. [Google Scholar] [CrossRef]
  29. Jane, J.; Chen, Y.Y.; Lee, L.F.; McPherson, A.E.; Wong, K.S.; Radosavljevic, M.; Kasemsuwan, T. Effects of amylopectin branch chain length and amylose content on the gelatinisation and pasting properties of starch. Cereal Chem. 1999, 76, 629–637. [Google Scholar] [CrossRef]
  30. Regina, A.; Blazek, J.; Gilbert, E.; Flanagan, B.M.; Gidley, M.J.; Cavanagh, C.; Ral, J.-P.; Larroque, O.; Bird, A.R.; Li, Z.; et al. Differential effects of genetically distinct mechanisms of elevating amylose on barley starch characteristics. Carbohydr. Polym. 2012, 89, 979–991. [Google Scholar] [CrossRef]
  31. Fan, X.Y.; Guo, M.; Li, R.D.; Yang, Y.H.; Liu, M.; Zhu, Q.; Tang, S.Z.; Gu, M.H.; Xu, R.G.; Yan, C.J. Allelic variations in the soluble starch synthase II gene family result in changes of grain quality and starch properties in rice (Oryza sativa L.). J. Agric. Sci. 2017, 155, 129–140. [Google Scholar] [CrossRef]
  32. Topping, D.L.; Morell, M.K.; King, R.A.; Li, Z.Y.; Bird, A.R.; Noakes, M. Resistant starch and health—Himalaya 292, a novel barley cultivar to deliver benefits to consumers. Starch-Stärke 2003, 55, 539–545. [Google Scholar] [CrossRef]
  33. Belobrajdic, D.P.; King, R.A.; Christophersen, C.T.; Bird, A.R. Dietary resistant starch dose-dependently reduces adiposity in obesity-prone and obesity-resistant male rats. Nutr. Metab. 2012, 9, 93. [Google Scholar] [CrossRef]
  34. Sano, Y. Differential regulation of waxy gene expression in rice endosperm. Theor. Appl. Genet. 1984, 68, 467–473. [Google Scholar] [CrossRef]
  35. Tian, Z.X.; Qian, Q.; Liu, Q.Q.; Yan, M.X.; Liu, X.F.; Yan, C.J.; Liu, G.F.; Gao, Z.Y.; Tang, S.Z.; Zeng, D.L.; et al. Allelic diversities in rice starch biosynthesis lead to a diverse array of rice eating and cooking qualities. Proc. Natl. Acad. Sci. USA 2009, 106, 21760–21765. [Google Scholar] [CrossRef] [PubMed]
  36. Bird, A.R.; Vuaran, M.S.; King, R.A.; Noakes, M.; Keogh, J.; Morell, M.K.; Topping, D.L. Wholegrain foods made from a novel high-amylose barley variety (Himalaya 292) improve indices of bowel health in human subjects. Br. J. Nutr. 2008, 99, 1032–1040. [Google Scholar] [CrossRef] [PubMed]
  37. Belobrajdic, D.P.; Jenkins, C.L.D.; Bushell, R.; Morell, M.K.; Bird, A.R. Fructan extracts from wheat stem and barley grain stimulate large bowel fermentation in rats. Nutr. Res. 2012, 32, 599–606. [Google Scholar] [CrossRef] [PubMed]
  38. Belobrajdic, D.P.; Jobling, S.A.; Morell, M.K.; Taketa, S.; Bird, A.R. Wholegrain barley β-glucan fermentation does not improve glucose tolerance in rats fed a high-fat diet. Nutr. Res. 2015, 35, 162–168. [Google Scholar] [CrossRef]
Figure 1. Genotype and immunoblot analyses of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant plants. (A) The sequence results of T0-60 and T0-89 mutant lines. WT, Golden Promise. The box, indicated by red dashed lines in each image, represents the gRNA region of the corresponding gene. The red arrows indicate the mutation site in the T0 plants at the corresponding gRNA site. (B) The mutation genotypes of the target genes in the selected homozygous T2 mutants. The line numbers of T2 plants are marked on the left side, and the names of the target genes are marked at the top of the sequences. GP represents the non-transgenic barley ‘Golden Promise’; WT indicates that no mutation was detected in the transgenic plant at the corresponding gRNA site. Italic letters with underlines indicate the PAM sequences of gRNA sites. The lowercase letters on a grey background represent the insertions, and the capital letters on a grey background represent the deletions of the nucleotides. (C) Starch granules from five independent T3 mutant lines and NE were used to extract the GBPs. The protein bands detected by various antibodies are indicated on the left side of each image. NE, non-genome-edited line.
Figure 1. Genotype and immunoblot analyses of ssIIa/ssIIIa/sbeIIa/sbeIIb mutant plants. (A) The sequence results of T0-60 and T0-89 mutant lines. WT, Golden Promise. The box, indicated by red dashed lines in each image, represents the gRNA region of the corresponding gene. The red arrows indicate the mutation site in the T0 plants at the corresponding gRNA site. (B) The mutation genotypes of the target genes in the selected homozygous T2 mutants. The line numbers of T2 plants are marked on the left side, and the names of the target genes are marked at the top of the sequences. GP represents the non-transgenic barley ‘Golden Promise’; WT indicates that no mutation was detected in the transgenic plant at the corresponding gRNA site. Italic letters with underlines indicate the PAM sequences of gRNA sites. The lowercase letters on a grey background represent the insertions, and the capital letters on a grey background represent the deletions of the nucleotides. (C) Starch granules from five independent T3 mutant lines and NE were used to extract the GBPs. The protein bands detected by various antibodies are indicated on the left side of each image. NE, non-genome-edited line.
Foods 14 02319 g001
Figure 2. Compositions of mutant barley grains. (A) Total starch content. (B) Apparent amylose content. (C) Resistant starch content. (D) β-glucan content. (E) Fructan content. (F) Dietary fibre content. The numbers in columns represent the means of five biological replicates and the standard errors of the corresponding parameters, respectively. The grey columns represent the contents of the different components of the non-genome-edited barley grains. The red columns represent the contents of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains. The yellow columns represent the content of corresponding components in the grains of ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb mutants. The data in grey font in the columns indicate that the data were published in a previous study [18]. Asterisks indicate the significant differences between the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains and other mutant grains, and non-genome-edited grains determined by Student’s t-test (** at p < 0.01).
Figure 2. Compositions of mutant barley grains. (A) Total starch content. (B) Apparent amylose content. (C) Resistant starch content. (D) β-glucan content. (E) Fructan content. (F) Dietary fibre content. The numbers in columns represent the means of five biological replicates and the standard errors of the corresponding parameters, respectively. The grey columns represent the contents of the different components of the non-genome-edited barley grains. The red columns represent the contents of the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains. The yellow columns represent the content of corresponding components in the grains of ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb mutants. The data in grey font in the columns indicate that the data were published in a previous study [18]. Asterisks indicate the significant differences between the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains and other mutant grains, and non-genome-edited grains determined by Student’s t-test (** at p < 0.01).
Foods 14 02319 g002
Figure 3. Amylose content, starch swelling power, and solubility of T3 mutants and NE barley grains. (A) Amylose content of starch from T3 mutants and NE grains measured by HPLC. The data in red and blue fonts indicate the amylose content of native and debranched starch from barley grains of the same genotype, respectively. (B) Swelling power and solubility of starch from T3 mutants and NE grains. The data in red and blue fonts indicate the swelling power and solubility of the same starch sample, respectively. The genotypes of barley lines are labelled on the x-axis. The numbers above the circles (hollow or solid) represent the means of five biological replicates, along with their standard errors. The data underlined indicate that the data were published in a previous study [18]. NE, non-genome-edited lines. Asterisks indicate the significant difference between the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains and other mutant grains, and NE determined by Student’s t-test (** at p < 0.01).
Figure 3. Amylose content, starch swelling power, and solubility of T3 mutants and NE barley grains. (A) Amylose content of starch from T3 mutants and NE grains measured by HPLC. The data in red and blue fonts indicate the amylose content of native and debranched starch from barley grains of the same genotype, respectively. (B) Swelling power and solubility of starch from T3 mutants and NE grains. The data in red and blue fonts indicate the swelling power and solubility of the same starch sample, respectively. The genotypes of barley lines are labelled on the x-axis. The numbers above the circles (hollow or solid) represent the means of five biological replicates, along with their standard errors. The data underlined indicate that the data were published in a previous study [18]. NE, non-genome-edited lines. Asterisks indicate the significant difference between the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant grains and other mutant grains, and NE determined by Student’s t-test (** at p < 0.01).
Foods 14 02319 g003
Figure 4. Differential patterns between ssIIa/ssIIIa/sbeIIa/sbeIIb and other mutants, and NE in the chain length distribution of debranched starches. The black, yellow, purple, blue, and red lines represent the differences between ssIIa/ssIIIa/sbeIIa/sbeIIb mutant and NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb mutant barley, respectively. NE, non-genome-edited line. The x-axis represents the DP sizes.
Figure 4. Differential patterns between ssIIa/ssIIIa/sbeIIa/sbeIIb and other mutants, and NE in the chain length distribution of debranched starches. The black, yellow, purple, blue, and red lines represent the differences between ssIIa/ssIIIa/sbeIIa/sbeIIb mutant and NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb mutant barley, respectively. NE, non-genome-edited line. The x-axis represents the DP sizes.
Foods 14 02319 g004
Figure 5. Starch granule morphologies and compositions in mutant barley grains. Starch granule morphologies are shown in ssIIa/ssIIIa/sbeIIa/sbeIIb null mutant (A); non-genome-edited (NE) control (B); ssIIa null mutant (C); ssIIIa null mutant (D); sbeIIa/sbeIIb null mutant (E); ssIIa/sbeIIa/sbeIIb null mutant (F). (G) shows differential patterns between ssIIa/ssIIIa/sbeIIa/sbeIIb and other mutants, and NE in the starch granule size distribution. The black, yellow, purple, blue, and red lines represent the differences between ssIIa/ssIIIa/sbeIIa/sbeIIb mutant and NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb mutant barley lines, respectively. NE, non-genome-edited lines. (H) shows starch granule compositions of starches from T3 mutants and NE grains. The columns in dark grey and light grey represent the percentage volumes of A-type and B-type starch granules, respectively. The mean ± SD data in the columns were calculated from five replicates. The data underlined indicates that the data were published in a previous study. Asterisks indicate a significant difference between the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant and other mutants and NE determined by Student’s t-test (* at p < 0.05; ** at p < 0.01). NE, non-genome-edited lines.
Figure 5. Starch granule morphologies and compositions in mutant barley grains. Starch granule morphologies are shown in ssIIa/ssIIIa/sbeIIa/sbeIIb null mutant (A); non-genome-edited (NE) control (B); ssIIa null mutant (C); ssIIIa null mutant (D); sbeIIa/sbeIIb null mutant (E); ssIIa/sbeIIa/sbeIIb null mutant (F). (G) shows differential patterns between ssIIa/ssIIIa/sbeIIa/sbeIIb and other mutants, and NE in the starch granule size distribution. The black, yellow, purple, blue, and red lines represent the differences between ssIIa/ssIIIa/sbeIIa/sbeIIb mutant and NE, ssIIa, ssIIIa, sbeIIa/sbeIIb, and ssIIa/sbeIIa/sbeIIb mutant barley lines, respectively. NE, non-genome-edited lines. (H) shows starch granule compositions of starches from T3 mutants and NE grains. The columns in dark grey and light grey represent the percentage volumes of A-type and B-type starch granules, respectively. The mean ± SD data in the columns were calculated from five replicates. The data underlined indicates that the data were published in a previous study. Asterisks indicate a significant difference between the ssIIa/ssIIIa/sbeIIa/sbeIIb mutant and other mutants and NE determined by Student’s t-test (* at p < 0.05; ** at p < 0.01). NE, non-genome-edited lines.
Foods 14 02319 g005
Table 1. Differences in chain length distribution between ssIIa/ssIIIa/sbeIIa/sbeIIb and other barley mutants.
Table 1. Differences in chain length distribution between ssIIa/ssIIIa/sbeIIa/sbeIIb and other barley mutants.
GenotypeDifferences in Chain Length Distribution (%)
DP6-12DP13-24DP25-36DP > 36
ssIIa/ssIIIa/sbeIIa/sbeIIbNE9.11−4.77−3.19−1.15
ssIIa/ssIIIa/sbeIIa/sbeIIbssIIa−5.049.16−3.20−0.92
ssIIa/ssIIIa/sbeIIa/sbeIIbssIIIa11.14−7.21−3.05−0.88
ssIIa/ssIIIa/sbeIIa/sbeIIbsbeIIa/sbeIIb8.66−8.710.010.04
ssIIa/ssIIIa/sbeIIa/sbeIIbssIIa/sbeIIa/sbeIIb2.02−2.640.460.16
Table 2. Differential compositions of starch granules between ssIIa/ssIIIa/sbeIIa/sbeIIb and other barley mutants.
Table 2. Differential compositions of starch granules between ssIIa/ssIIIa/sbeIIa/sbeIIb and other barley mutants.
GenotypeDifferential Compositions of Starch Granules (%)
B Granule
(1–10 μm)
A1 Granule
(10–20 μm)
A2 Granule
(20–60 μm)
A3 Granule
(60–120 μm)
ssIIa/ssIIIa/sbeIIa/sbeIIbNE1.063.45−7.923.41
ssIIa/ssIIIa/sbeIIa/sbeIIbssIIa−8.9512.03−1.79−1.27
ssIIa/ssIIIa/sbeIIa/sbeIIbssIIIa−15.516.985.093.41
ssIIa/ssIIIa/sbeIIa/sbeIIbsbeIIa/sbeIIb−4.189.91−5.49−0.25
ssIIa/ssIIIa/sbeIIa/sbeIIbssIIa/sbeIIa/sbeIIb−9.165.71.921.53
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yang, Q.; Ral, J.-P.; Jiang, Q.; Li, Z. Engineering High-Amylose and High-Dietary-Fibre Barley Grains Through Multiplex Genome Editing of Four Starch-Synthetic Genes. Foods 2025, 14, 2319. https://doi.org/10.3390/foods14132319

AMA Style

Yang Q, Ral J-P, Jiang Q, Li Z. Engineering High-Amylose and High-Dietary-Fibre Barley Grains Through Multiplex Genome Editing of Four Starch-Synthetic Genes. Foods. 2025; 14(13):2319. https://doi.org/10.3390/foods14132319

Chicago/Turabian Style

Yang, Qiang, Jean-Philippe Ral, Qiantao Jiang, and Zhongyi Li. 2025. "Engineering High-Amylose and High-Dietary-Fibre Barley Grains Through Multiplex Genome Editing of Four Starch-Synthetic Genes" Foods 14, no. 13: 2319. https://doi.org/10.3390/foods14132319

APA Style

Yang, Q., Ral, J.-P., Jiang, Q., & Li, Z. (2025). Engineering High-Amylose and High-Dietary-Fibre Barley Grains Through Multiplex Genome Editing of Four Starch-Synthetic Genes. Foods, 14(13), 2319. https://doi.org/10.3390/foods14132319

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop